Bristol-Myers Squibb Company Logo

Bristol-Myers Squibb Company (BMY)

SIX

Currency in CHF
53.72
+0.21 (+0.39%)

Real-time Data

07:00 AM

Day's Range

53.72
53.72

52 wk Range

42.54
53.90

Overview - BMY - Bristol-Myers Squibb Company

Key Statistics

Valuation

Enterprise Value

114.83B

P/E (Trailing)

‪14.41‬

PEG Ratio

‪0.09‬

Price / Sales (TTM)

‪2.19‬

Price / Book

‪5.93‬

EV / EBITDA

‪7.59‬

Profitability

Gross Margin

‪71.27%‬

Profit Margin

‪18.87%‬

Operating Margin

‪34.41%‬

Return on Assets

‪10.71%‬

Return on Equity

‪46.59%‬

Ownership

Shares Outstanding

2.04B

Float

2.03B

Held by Insiders

‪0.09%‬

Held by Institutions

‪84.68%‬

Price stats

Beta

‪0.22‬

50-Day Avg

‪48.69‬

200-Day Avg

‪46.72‬

Dividends

Payout Ratio

‪27.75%‬

Frequency

Annual

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 17, 2025

Screened by Zoya using the AAOIFI methodology.

Peers - BMY - Bristol-Myers Squibb Company

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on SIX.

Profile Summary - BMY - Bristol-Myers Squibb Company

About

Bristol-Myers Squibb Company is a global biopharmaceutical company headquartered in Princeton, New Jersey, and founded in 1933. It discovers, develops, licenses, manufactures, markets, distributes, and sells innovative medicines addressing serious diseases worldwide. The company offers a diverse portfolio including…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees32.50K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.